Does pregnancy loss mean future CVD risk?

Article

Women who have a history of pregnancy loss, either miscarriage or stillbirth, may be at greater risk of postmenopausal cardiovascular disease (CVD), according to a recent study in The Annals of Family Medicine.

 

Women who have a history of pregnancy loss, either miscarriage or stillbirth, may be at greater risk of postmenopausal cardiovascular disease (CVD), according to a recent study in The Annals of Family Medicine.

Led by researchers at Brown University, the analysis was based on data from the Women’s Health Initiative cohort of 77,701 women who were evaluated from 1993 to 1998. Information on baseline reproductive history, sociodemographic, and CVD risk factors was collected. Multiple logistic regression was used to evaluate the association between 1 or 2 or more miscarriages and 1 or more stillbirths with occurrences of CVD.

In the study sample, 23,538 women (30.3%) reported a history of miscarriage; 1670 (2.2%) reported a stillbirth, and 1673 women reported a history of stillbirth and miscarriage. When compared with no stillbirth history, women with 1 or more stillbirths had an adjusted odds ratio (aOR) of 1.27 (95% confidence interval [CI], 1.07-1.51) for coronary heart disease (CHD). For women with a history of 1 miscarriage, the aOR was 1.19 (95% CI 1.08-1.32) for CHD; in women with 2 or more miscarriages the aOR was 1.18 (95% CI, 1.04-1.34). The multivariable odds ratio for ischemic stroke and stillbirths and miscarriages was not considered significant.

The researchers concluded that pregnancy loss was associated with CHD but not with ischemic stroke. Women with a history of pregnancy loss should be considered for close cardiovascular surveillance and potentially early invention. The researchers believe that further research is needed to understand the mechanisms behind theincreased risk of CVD associated with pregnancy loss.


 

 

To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.

Recent Videos
Eran Bornstein, MD, highlights early signs of preeclampsia clinicians need to know | Image Credit: northwell.edu.
Eran Bornstein, MD explains the need for first trimester preeclampsia screening | Image Credit: northwell.edu.
Veerle Bergink, MD, PhD, highlights familial links of postpartum psychosis | Image Credit: profiles.mountsinai.org.
Ivie Odiase, MD
Amy Valent DO, MCR, highlights new tech for prenatal diabetes management | Image Credit: linkedin.com.
Johanna Finkle, MD, weight loss specialist, OB/GYN, The University of Kansas Health System.
Laxmi Gannu, MD, notes PPD screening gaps and adverse outcomes | Image Credit: linkedin.com.
Farah Amro, MD
Laurence Shields, MD, is System Physician Vice President at the Women and Infants Clinical Institute with CommonSpirit Health in Santa Maria, California.
Joy Baker, MD, FACOG, highlights how to recognize PPD | Image Credit: linkedin.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.